Follow
Arun Pandian Chandrasekaran
Arun Pandian Chandrasekaran
Postdoc, BESE Division, KAUST
Verified email at kaust.edu.sa - Homepage
Title
Cited by
Cited by
Year
Evaluation of the potential of cassava-based residues for biofuels production
S Sivamani, AP Chandrasekaran, M Balajii, M Shanmugaprakash, ...
Reviews in Environmental Science and Bio/Technology, 2018
842018
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
N Poondla, AP Chandrasekaran, KS Kim, S Ramakrishna
BMB reports 52 (3), 181, 2019
752019
Different methods of delivering CRISPR/Cas9 into cells
AP Chandrasekaran, M Song, KS Kim, S Ramakrishna
Progress in molecular biology and translational science 159, 157-176, 2018
592018
Progress in molecular biology and translational science
DB Teplow
Academic Press, 2018
532018
Genome-scale screening of deubiquitinase subfamily identifies USP3 as a stabilizer of Cdc25A regulating cell cycle in cancer
S Das, AP Chandrasekaran, B Suresh, S Haq, JH Kang, SJ Lee, J Kim, ...
Cell Death & Differentiation 27 (11), 3004-3020, 2020
352020
Concise review: fate determination of stem cells by deubiquitinating enzymes
AP Chandrasekaran, B Suresh, H Kim, KS Kim, S Ramakrishna
Stem Cells 35 (1), 9-16, 2017
292017
The stability and oncogenic function of LIN28A are regulated by USP28
S Haq, S Das, DH Kim, AP Chandrasekaran, SH Hong, KS Kim, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (3), 599-610, 2019
242019
Response surface optimization of acid pretreatment of cassava stem for bioethanol production
S Sivamani, R Baskar, AP Chandrasekaran
Environmental Progress & Sustainable Energy, 2019
172019
Ubiquitin specific protease 29 functions as an oncogene promoting tumorigenesis in colorectal carcinoma
AP Chandrasekaran, B Suresh, N Sarodaya, NR Ko, SJ Oh, KS Kim, ...
Cancers 13 (11), 2706, 2021
162021
USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2
AP Chandrasekaran, K Kaushal, CH Park, KS Kim, S Ramakrishna
Theranostics 11 (20), 9752, 2021
162021
Statistical modeling and optimization of pretreatment for fermentable sugars production from cotton gin waste
AP Chandrasekaran, S Sivamani
Energy Sources, Part A: Recovery, Utilization, and Environmental Effects 40 …, 2018
152018
Genome editing: a robust technology for human stem cells
AP Chandrasekaran, M Song, S Ramakrishna
Cellular and Molecular Life Sciences, 1-12, 2017
152017
Dual role of deubiquitinating enzyme USP19 regulates mitotic progression and tumorigenesis by stabilizing survivin
AP Chandrasekaran, A Tyagi, N Poondla, N Sarodaya, JK Karapurkar, ...
Molecular Therapy 30 (11), 3414-3429, 2022
112022
CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells
A Tyagi, K Kaushal, AP Chandrasekaran, N Sarodaya, S Das, CH Park, ...
Theranostics 12 (13), 5949, 2022
112022
Ubiquitin-specific protease 29 regulates Cdc25A-mediated tumorigenesis
AP Chandrasekaran, SH Woo, N Sarodaya, BH Rhie, A Tyagi, S Das, ...
International Journal of Molecular Sciences 22 (11), 5766, 2021
112021
E3 Ubiquitin Ligase APC/CCdh1 Regulation of Phenylalanine Hydroxylase Stability and Function
A Tyagi, N Sarodaya, K Kaushal, AP Chandrasekaran, AM Antao, ...
International Journal of Molecular Sciences 21 (23), 9076, 2020
112020
CRISPR-mediated upregulation of DR5 and downregulation of cFLIP synergistically sensitize HeLa cells to TRAIL-mediated apoptosis
N Poondla, AP Chandrasekaran, K Heese, KS Kim, S Ramakrishna
Biochemical and biophysical research communications 512 (1), 60-65, 2019
112019
Characterization of combined organic–inorganic acid-pretreated cassava stem
AP Chandrasekaran, S Sivamani, V Ranjithkumar
International Journal of Environmental Science and Technology, 6, 2017
112017
HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response
S Das, AP Chandrasekaran, KS Jo, NR Ko, SJ Oh, KS Kim, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 118835, 2020
82020
The role of the CRISPR‐Cas system in cancer drug development: Mechanisms of action and therapy
AP Chandrasekaran, JK Karapurkar, HY Chung, S Ramakrishna
Biotechnology Journal 17 (7), 2100468, 2022
72022
The system can't perform the operation now. Try again later.
Articles 1–20